Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
February 7, 2017
Cholinergic Receptor Binding in Alzheimer Disease and Healthy Aging: Assessment In Vivo with Positron Emission Tomography Imaging
David L Sultzer, Rebecca J Melrose, Hannah Riskin-Jones, et al.
The New England Journal of Medicine
|
October 19, 2012
Relapse risk after discontinuation of risperidone in Alzheimer's disease
D P Devanand, Jacobo Mintzer, Susan K Schultz, et al.
The American Journal of Psychiatry
|
June 4, 2008
Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial
David L Sultzer, Sonia M Davis, Pierre N Tariot, et al.
The American Journal of Psychiatry
|
April 17, 2009
Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study
Ling Zheng, Wendy J Mack, Karen S Dagerman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 9, 2025
Neuropsychiatric symptoms and emerging dementia in people with Down syndrome and older adults
Christina M Magana-Ramirez, Daniel L Gillen, Christy L Hom, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Clinical Manifestations
Christina M Magana-Ramirez, Daniel L Gillen, Christy L Hom, et al.
The New England Journal of Medicine
|
July 21, 2021
Trial of Pimavanserin in Dementia-Related Psychosis
Pierre N Tariot, Jeffrey L Cummings, Maria E Soto-Martin, et al.
The American Journal of Psychiatry
|
November 19, 2016
Prediction of Relapse After Discontinuation of Antipsychotic Treatment in Alzheimer's Disease: The Role of Hallucinations
Anjali N Patel, Seonjoo Lee, Howard F Andrews, et al.
Journal of Psychiatric Research
|
May 11, 2024
Deep brain stimulation of the amygdala for treatment-resistant combat post-traumatic stress disorder: Long-term results
Ralph J Koek, Josue Avecillas-Chasin, Scott E Krahl, et al.
The New England Journal of Medicine
|
October 13, 2006
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease
Lon S Schneider, Pierre N Tariot, Karen S Dagerman, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
February 7, 2017
Cholinergic Receptor Binding in Alzheimer Disease and Healthy Aging: Assessment In Vivo with Positron Emission Tomography Imaging
David L Sultzer, Rebecca J Melrose, Hannah Riskin-Jones, et al.
The New England Journal of Medicine
|
October 19, 2012
Relapse risk after discontinuation of risperidone in Alzheimer's disease
D P Devanand, Jacobo Mintzer, Susan K Schultz, et al.
The American Journal of Psychiatry
|
June 4, 2008
Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial
David L Sultzer, Sonia M Davis, Pierre N Tariot, et al.
The American Journal of Psychiatry
|
April 17, 2009
Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study
Ling Zheng, Wendy J Mack, Karen S Dagerman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 9, 2025
Neuropsychiatric symptoms and emerging dementia in people with Down syndrome and older adults
Christina M Magana-Ramirez, Daniel L Gillen, Christy L Hom, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Clinical Manifestations
Christina M Magana-Ramirez, Daniel L Gillen, Christy L Hom, et al.
The New England Journal of Medicine
|
July 21, 2021
Trial of Pimavanserin in Dementia-Related Psychosis
Pierre N Tariot, Jeffrey L Cummings, Maria E Soto-Martin, et al.
The American Journal of Psychiatry
|
November 19, 2016
Prediction of Relapse After Discontinuation of Antipsychotic Treatment in Alzheimer's Disease: The Role of Hallucinations
Anjali N Patel, Seonjoo Lee, Howard F Andrews, et al.
Journal of Psychiatric Research
|
May 11, 2024
Deep brain stimulation of the amygdala for treatment-resistant combat post-traumatic stress disorder: Long-term results
Ralph J Koek, Josue Avecillas-Chasin, Scott E Krahl, et al.
The New England Journal of Medicine
|
October 13, 2006
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease
Lon S Schneider, Pierre N Tariot, Karen S Dagerman, et al.
Page
of 7